XML 23 R10.htm IDEA: XBRL DOCUMENT
v3.22.2.2

CONSOLIDATED SCHEDULE OF INVESTMENTS (Parenthetical) $ in Thousands | Sep. 30, 2022 USD ($) Firm | Dec. 31, 2021 USD ($) Firm
--- | --- | ---
Investment Holdings [Line Items] |  |  |  |  |
Tax basis of investments, gross, unrealized appreciation |  | $ 68,400 |  | $ 121,000 |
Tax basis of investments, gross, unrealized depreciation |  | 110,000 |  | 75,700 |
Tax basis of investments, unrealized appreciation (depreciation), net |  | 41,600 |  | 45,300 |
Tax basis of investments, cost for income tax purposes |  | 2,900,000 |  | 2,400,000 |
Investment Owned At Cost |  | 2,869,469 |  | 2,390,984 |
Investment Owned At Fair Value |  | 2,825,738 |  | 2,434,522 |
Black Crow AI, Inc. affiliates |  |  |  |  |
Investment Holdings [Line Items] |  |  |  |  |
Investment Owned Balance Principal Amount |  |  |  | $ 3,000 |
Promissory Notes [Member] | Black Crow AI, Inc. affiliates |  |  |  |  |
Investment Holdings [Line Items] |  |  |  |  |
Investment Owned Balance Principal Amount |  | $ 3,000 |  |  |
PRIME |  |  |  |  |
Investment Holdings [Line Items] |  |  |  |  |
Interest rate |  | 6.25% |  | 3.25% |
1-month LIBOR |  |  |  |  |
Investment Holdings [Line Items] |  |  |  |  |
Interest rate |  | 3.1427% |  | 0.14% |
3-month LIBOR |  |  |  |  |
Investment Holdings [Line Items] |  |  |  |  |
Interest rate |  | 3.7547% |  | 0.24% |
6-month LIBOR |  |  |  |  |
Investment Holdings [Line Items] |  |  |  |  |
Interest rate |  | 4.232% |  | 0.26% |
Warrant |  |  |  |  |
Investment Holdings [Line Items] |  |  |  |  |
Investment owned, percent of net assets | [1] | 1.99% |  |  |
Investment Owned At Fair Value |  | $ 27,159 |  | $ 38,399 |
Warrant | Fair Value Inputs Level1 [Member] |  |  |  |  |
Investment Holdings [Line Items] |  |  |  |  |
Number of publicly traded companies | Firm |  | 27 |  | 26 |
Total Investments Before Cash And Cash Equivalent [Member] |  |  |  |  |
Investment Holdings [Line Items] |  |  |  |  |
Investment owned, percent of net assets | [1] | 207.36% |  |  |
Investment Owned At Cost | [1],[2] | $ 2,869,469 |  |  |
Investment Owned At Fair Value |  | $ 2,825,738 |  |  |
Total investments In Securities |  |  |  |  |
Investment Holdings [Line Items] |  |  |  |  |
Investment owned, percent of net assets | [1] | 207.14% |  |  |
Investment Owned At Cost | [2] | $ 2,866,330 |  |  |
Investment Owned At Fair Value |  | $ 2,822,692 |  |  |
Total Investments with Cash and Cash Equivalents |  |  |  |  |
Investment Holdings [Line Items] |  |  |  |  |
Investment owned, percent of net assets | [1] | 209.19% |  |  |
Investment Owned At Cost | [1],[2] | $ 2,894,469 |  |  |
Investment Owned At Fair Value | [1] | $ 2,850,738 |  |  |
Money Market Funds [Member] |  |  |  |  |
Investment Holdings [Line Items] |  |  |  |  |
Investment owned, percent of net assets | [1] | 1.83% |  |  |
Investment Owned At Cost | [1],[2] | $ 25,000 |  |  |
Investment Owned At Fair Value | [1] | $ 25,000 |  |  |
Investment Funds And Vehicles [Member] |  |  |  |  |
Investment Holdings [Line Items] |  |  |  |  |
Investment owned, percent of net assets | [1] | 0.22% |  |  |
Common Stock |  |  |  |  |
Investment Holdings [Line Items] |  |  |  |  |
Investment Owned At Fair Value |  | $ 93,096 |  | $ 115,271 |
Common Stock | Fair Value Inputs Level1 [Member] |  |  |  |  |
Investment Holdings [Line Items] |  |  |  |  |
Number of publicly traded companies | Firm |  | 42 |  | 36 |
Equity |  |  |  |  |
Investment Holdings [Line Items] |  |  |  |  |
Investment owned, percent of net assets |  | 9.84% | [1] | 14.12% | [3]
Investment Owned At Cost |  | $ 150,539 | [2] | $ 142,219 | [4]
Investment Owned At Fair Value |  | 134,134 |  | $ 184,710 |
Warrant Investment |  |  |  |  |
Investment Holdings [Line Items] |  |  |  |  |
Investment owned, percent of net assets | [3] |  |  | 2.93% |
Investment Owned At Cost |  | 31,148 | [2] | $ 27,147 | [4]
Investment Owned At Fair Value |  | $ 27,159 |  | $ 38,399 |
Debt Investment [Member] |  |  |  |  |
Investment Holdings [Line Items] |  |  |  |  |
Investment owned, percent of net assets |  | 195.30% | [1] | 168.86% | [3]
Investments in Securities [Member] |  |  |  |  |
Investment Holdings [Line Items] |  |  |  |  |
Investment owned, percent of net assets | [3] |  |  | 185.91% |
Investment Owned At Cost | [4] |  |  | $ 2,388,952 |
Investment Owned At Fair Value |  |  |  | $ 2,432,708 |
Investment Funds & Vehicles [Member] |  |  |  |  |
Investment Holdings [Line Items] |  |  |  |  |
Investment owned, percent of net assets | [3] |  |  | 0.14% |
Investment Owned At Cost | [2] | $ 3,139 |  |  |
Investment Owned At Fair Value |  | 3,046 |  |  |
Investment [Member] |  |  |  |  |
Investment Holdings [Line Items] |  |  |  |  |
Investment owned, percent of net assets | [3] |  |  | 186.05% |
Investment Owned At Cost | [4] |  |  | $ 2,390,984 |
Investment Owned At Fair Value |  |  |  | 2,434,522 |
Phathom Pharmaceuticals, Inc. | Royalty Contract |  |  |  |  |
Investment Holdings [Line Items] |  |  |  |  |
Investment Owned At Cost |  | 4,600 |  |  |
Investment Owned At Fair Value |  | 4,300 |  |  |
Internet Consumer And Business Services |  |  |  |  |
Investment Holdings [Line Items] |  |  |  |  |
Investment Owned At Fair Value |  | $ 489,968 |  | $ 395,506 |
Internet Consumer And Business Services | Warrant |  |  |  |  |
Investment Holdings [Line Items] |  |  |  |  |
Investment owned, percent of net assets | [1] | 0.43% |  |  |
Internet Consumer And Business Services | Equity |  |  |  |  |
Investment Holdings [Line Items] |  |  |  |  |
Investment owned, percent of net assets |  | 1.13% | [1] | 2.70% | [3]
Investment Owned At Cost |  | $ 22,058 | [2] | $ 22,151 | [4]
Investment Owned At Fair Value |  | 15,377 |  | $ 35,331 |
Internet Consumer And Business Services | Warrant Investment |  |  |  |  |
Investment Holdings [Line Items] |  |  |  |  |
Investment owned, percent of net assets | [3] |  |  | 0.78% |
Investment Owned At Cost |  | 6,110 | [2] | $ 4,992 | [4]
Investment Owned At Fair Value |  | $ 5,800 |  | $ 10,212 |
Internet Consumer And Business Services | Debt Investment [Member] |  |  |  |  |
Investment Holdings [Line Items] |  |  |  |  |
Investment owned, percent of net assets |  | 34.40% |  | 26.74% | [3]
Surgical Devices |  |  |  |  |
Investment Holdings [Line Items] |  |  |  |  |
Investment Owned At Fair Value |  | $ 1,536 |  | $ 1,029 |
Surgical Devices | Warrant |  |  |  |  |
Investment Holdings [Line Items] |  |  |  |  |
Investment owned, percent of net assets | [1] | 0.11% |  |  |
Surgical Devices | Equity |  |  |  |  |
Investment Holdings [Line Items] |  |  |  |  |
Investment owned, percent of net assets |  | 0.00% | [1] | 0.04% | [3]
Investment Owned At Cost |  | $ 1,941 | [2] | $ 1,941 | [4]
Investment Owned At Fair Value |  | 0 |  | $ 543 |
Surgical Devices | Warrant Investment |  |  |  |  |
Investment Holdings [Line Items] |  |  |  |  |
Investment owned, percent of net assets | [3] |  |  | 0.04% |
Investment Owned At Cost |  | 152 | [2] | $ 206 | [4]
Investment Owned At Fair Value |  | $ 1,536 |  | $ 486 |
Media/Content/Info | Warrant |  |  |  |  |
Investment Holdings [Line Items] |  |  |  |  |
Investment owned, percent of net assets | [1] | 0.00% |  |  |
Media/Content/Info | Warrant Investment |  |  |  |  |
Investment Holdings [Line Items] |  |  |  |  |
Investment owned, percent of net assets | [3] |  |  | 0.00% |
Investment Owned At Cost |  | $ 348 | [2] | $ 348 | [4]
Investment Owned At Fair Value |  | 0 |  | 0 |
Consumer & Business Products |  |  |  |  |
Investment Holdings [Line Items] |  |  |  |  |
Investment Owned At Fair Value |  | $ 25,497 |  | $ 28,099 |
Consumer & Business Products | Warrant |  |  |  |  |
Investment Holdings [Line Items] |  |  |  |  |
Investment owned, percent of net assets | [1] | 0.08% |  |  |
Consumer & Business Products | Equity |  |  |  |  |
Investment Holdings [Line Items] |  |  |  |  |
Investment owned, percent of net assets |  | 0.01% | [1] | 0.03% | [3]
Investment Owned At Cost |  | $ 561 | [2] | $ 128 | [4]
Investment Owned At Fair Value |  | 185 |  | $ 447 |
Consumer & Business Products | Warrant Investment |  |  |  |  |
Investment Holdings [Line Items] |  |  |  |  |
Investment owned, percent of net assets | [3] |  |  | 0.33% |
Investment Owned At Cost |  | 1,712 | [2] | $ 2,145 | [4]
Investment Owned At Fair Value |  | $ 1,122 |  | $ 4,354 |
Consumer & Business Products | Debt Investment [Member] |  |  |  |  |
Investment Holdings [Line Items] |  |  |  |  |
Investment owned, percent of net assets |  | 1.78% | [1] | 1.78% | [3]
Diversified Financial Services |  |  |  |  |
Investment Holdings [Line Items] |  |  |  |  |
Investment Owned At Fair Value |  | $ 72,061 |  | $ 65,073 |
Diversified Financial Services | Equity |  |  |  |  |
Investment Holdings [Line Items] |  |  |  |  |
Investment owned, percent of net assets |  | 2.79% | [1] | 2.49% | [3]
Investment Owned At Cost |  | $ 28,444 | [2] | $ 28,041 | [4]
Investment Owned At Fair Value |  | $ 38,022 |  | $ 32,608 |
Diversified Financial Services | Debt Investment [Member] |  |  |  |  |
Investment Holdings [Line Items] |  |  |  |  |
Investment owned, percent of net assets |  | 2.50% | [1] | 2.48% | [3]
Electronics & Computer Hardware |  |  |  |  |
Investment Holdings [Line Items] |  |  |  |  |
Investment Owned At Fair Value |  | $ 2,498 |  | $ 1,040 |
Electronics & Computer Hardware | Warrant |  |  |  |  |
Investment Holdings [Line Items] |  |  |  |  |
Investment owned, percent of net assets | [1] | 0.11% |  |  |
Electronics & Computer Hardware | Equity |  |  |  |  |
Investment Holdings [Line Items] |  |  |  |  |
Investment owned, percent of net assets | [1] | 0.08% |  |  |
Investment Owned At Cost | [2] | $ 1,500 |  |  |
Investment Owned At Fair Value |  | 1,034 |  |  |
Electronics & Computer Hardware | Warrant Investment |  |  |  |  |
Investment Holdings [Line Items] |  |  |  |  |
Investment owned, percent of net assets | [3] |  |  | 0.08% |
Investment Owned At Cost |  | 692 | [2] | $ 658 | [4]
Investment Owned At Fair Value |  | 1,464 |  | 1,040 |
Healthcare Services Other |  |  |  |  |
Investment Holdings [Line Items] |  |  |  |  |
Investment Owned At Fair Value |  | $ 203,599 |  | $ 121,003 |
Healthcare Services Other | Warrant |  |  |  |  |
Investment Holdings [Line Items] |  |  |  |  |
Investment owned, percent of net assets | [1] | 0.04% |  |  |
Healthcare Services Other | Equity |  |  |  |  |
Investment Holdings [Line Items] |  |  |  |  |
Investment owned, percent of net assets |  | 0.23% | [1] | 0.56% | [3]
Investment Owned At Cost |  | $ 6,782 | [2] | $ 6,781 | [4]
Investment Owned At Fair Value |  | 3,198 |  | $ 7,364 |
Healthcare Services Other | Warrant Investment |  |  |  |  |
Investment Holdings [Line Items] |  |  |  |  |
Investment Owned At Cost | [2] | 697 |  |  |
Investment Owned At Fair Value |  | $ 521 |  |  |
Healthcare Services Other | Debt Investment [Member] |  |  |  |  |
Investment Holdings [Line Items] |  |  |  |  |
Investment owned, percent of net assets |  | 14.67% | [1] | 8.68% | [3]
Drug Delivery |  |  |  |  |
Investment Holdings [Line Items] |  |  |  |  |
Investment Owned At Fair Value |  | $ 90 |  | $ 368 |
Drug Delivery | Warrant |  |  |  |  |
Investment Holdings [Line Items] |  |  |  |  |
Investment owned, percent of net assets | [1] | 0.00% |  |  |
Drug Delivery | Equity |  |  |  |  |
Investment Holdings [Line Items] |  |  |  |  |
Investment owned, percent of net assets |  | 0.01% | [1] | 0.02% | [3]
Investment Owned At Cost |  | $ 3,638 | [2] | $ 3,638 | [4]
Investment Owned At Fair Value |  |  |  | $ 305 |
Drug Delivery | Warrant Investment |  |  |  |  |
Investment Holdings [Line Items] |  |  |  |  |
Investment owned, percent of net assets | [3] |  |  | 0.00% |
Investment Owned At Cost |  | 465 | [2] | $ 465 | [4]
Investment Owned At Fair Value |  | 0 |  | 63 |
Communications & Networking |  |  |  |  |
Investment Holdings [Line Items] |  |  |  |  |
Investment Owned At Fair Value |  | $ 101,094 |  | $ 105,490 |
Communications & Networking | Warrant |  |  |  |  |
Investment Holdings [Line Items] |  |  |  |  |
Investment owned, percent of net assets | [1] | 0.01% |  |  |
Communications & Networking | Equity |  |  |  |  |
Investment Holdings [Line Items] |  |  |  |  |
Investment owned, percent of net assets | [3] |  |  | 0.48% |
Investment Owned At Cost | [4] |  |  | $ 1,230 |
Investment Owned At Fair Value |  |  |  | $ 6,260 |
Communications & Networking | Warrant Investment |  |  |  |  |
Investment Holdings [Line Items] |  |  |  |  |
Investment owned, percent of net assets | [3],[5] |  |  | 0.00% |
Investment Owned At Cost |  | $ 541 | [2] | $ 418 | [4]
Investment Owned At Fair Value |  | $ 140 |  | $ 0 |
Communications & Networking | Debt Investment [Member] |  |  |  |  |
Investment Holdings [Line Items] |  |  |  |  |
Investment owned, percent of net assets |  | 7.41% | [1] | 7.58% | [3]
Drug Discovery & Development |  |  |  |  |
Investment Holdings [Line Items] |  |  |  |  |
Investment Owned At Fair Value |  | $ 1,091,827 |  | $ 967,383 |
Drug Discovery & Development | Warrant |  |  |  |  |
Investment Holdings [Line Items] |  |  |  |  |
Investment owned, percent of net assets | [1] | 0.30% |  |  |
Drug Discovery & Development | Investment Funds And Vehicles [Member] |  |  |  |  |
Investment Holdings [Line Items] |  |  |  |  |
Investment owned, percent of net assets | [1] | 0.20% |  |  |
Drug Discovery & Development | Equity |  |  |  |  |
Investment Holdings [Line Items] |  |  |  |  |
Investment owned, percent of net assets |  | 2.41% | [1] | 1.90% | [3]
Investment Owned At Cost |  | $ 42,548 | [2] | $ 33,401 | [4]
Investment Owned At Fair Value |  | 32,844 |  | $ 24,860 |
Drug Discovery & Development | Warrant Investment |  |  |  |  |
Investment Holdings [Line Items] |  |  |  |  |
Investment owned, percent of net assets | [3] |  |  | 0.36% |
Investment Owned At Cost |  | 7,709 | [2] | $ 7,393 | [4]
Investment Owned At Fair Value |  | $ 4,074 |  | $ 4,745 |
Drug Discovery & Development | Debt Investment [Member] |  |  |  |  |
Investment Holdings [Line Items] |  |  |  |  |
Investment owned, percent of net assets |  | 77.22% | [1] | 71.53% | [3]
Drug Discovery & Development | Investment Funds & Vehicles [Member] |  |  |  |  |
Investment Holdings [Line Items] |  |  |  |  |
Investment Owned At Cost | [2] | $ 2,758 |  |  |
Investment Owned At Fair Value |  | 2,665 |  |  |
Medical Devices & Equipment |  |  |  |  |
Investment Holdings [Line Items] |  |  |  |  |
Investment Owned At Fair Value |  | $ 17,421 |  | $ 12,612 |
Medical Devices & Equipment | Warrant |  |  |  |  |
Investment Holdings [Line Items] |  |  |  |  |
Investment owned, percent of net assets | [1] | 0.03% |  |  |
Medical Devices & Equipment | Equity |  |  |  |  |
Investment Holdings [Line Items] |  |  |  |  |
Investment owned, percent of net assets |  | 0.16% | [1] | 0.81% | [3]
Investment Owned At Cost |  | $ 2,953 | [2] | $ 3,991 | [4]
Investment Owned At Fair Value |  | 2,143 |  | $ 10,538 |
Medical Devices & Equipment | Warrant Investment |  |  |  |  |
Investment Holdings [Line Items] |  |  |  |  |
Investment owned, percent of net assets | [3] |  |  | 0.16% |
Investment Owned At Cost |  | 2,035 | [2] | $ 2,483 | [4]
Investment Owned At Fair Value |  | $ 443 |  | 2,074 |
Medical Devices & Equipment | Debt Investment [Member] |  |  |  |  |
Investment Holdings [Line Items] |  |  |  |  |
Investment owned, percent of net assets | [1] | 1.09% |  |  |
Sustainable And Renewable Technology |  |  |  |  |
Investment Holdings [Line Items] |  |  |  |  |
Investment Owned At Fair Value |  | $ 15,683 |  | $ 39,387 |
Sustainable And Renewable Technology | Warrant |  |  |  |  |
Investment Holdings [Line Items] |  |  |  |  |
Investment owned, percent of net assets | [1] | 0.03% |  |  |
Sustainable And Renewable Technology | Equity |  |  |  |  |
Investment Holdings [Line Items] |  |  |  |  |
Investment owned, percent of net assets |  | 0.62% | [1] | 0.86% | [3]
Investment Owned At Cost |  | $ 11,508 | [2] | $ 12,412 | [4]
Investment Owned At Fair Value |  | 8,406 |  | $ 11,228 |
Sustainable And Renewable Technology | Warrant Investment |  |  |  |  |
Investment Holdings [Line Items] |  |  |  |  |
Investment owned, percent of net assets | [3] |  |  | 0.08% |
Investment Owned At Cost |  | 792 | [2] | $ 950 | [4]
Investment Owned At Fair Value |  | $ 373 |  | $ 1,034 |
Sustainable And Renewable Technology | Debt Investment [Member] |  |  |  |  |
Investment Holdings [Line Items] |  |  |  |  |
Investment owned, percent of net assets |  | 0.51% | [1] | 2.07% | [3]
Software |  |  |  |  |
Investment Holdings [Line Items] |  |  |  |  |
Investment Owned At Fair Value |  | $ 680,216 |  | $ 585,622 |
Software | Warrant |  |  |  |  |
Investment Holdings [Line Items] |  |  |  |  |
Investment owned, percent of net assets | [1] | 0.46% |  |  |
Software | Investment Funds And Vehicles [Member] |  |  |  |  |
Investment Holdings [Line Items] |  |  |  |  |
Investment owned, percent of net assets | [1] | 0.03% |  |  |
Software | Equity |  |  |  |  |
Investment Holdings [Line Items] |  |  |  |  |
Investment owned, percent of net assets |  | 1.83% | [1] | 3.45% | [3]
Investment Owned At Cost |  | $ 24,006 | [2] | $ 23,905 | [4]
Investment Owned At Fair Value |  | 24,997 |  | $ 45,087 |
Software | Warrant Investment |  |  |  |  |
Investment Holdings [Line Items] |  |  |  |  |
Investment owned, percent of net assets | [3] |  |  | 0.85% |
Investment Owned At Cost |  | 7,639 | [2] | $ 5,594 | [4]
Investment Owned At Fair Value |  | $ 6,217 |  | $ 11,133 |
Software | Debt Investment [Member] |  |  |  |  |
Investment Holdings [Line Items] |  |  |  |  |
Investment owned, percent of net assets |  | 47.60% | [1] | 40.46% | [3]
Software | Investment Funds & Vehicles [Member] |  |  |  |  |
Investment Holdings [Line Items] |  |  |  |  |
Investment Owned At Cost | [2] | $ 381 |  |  |
Investment Owned At Fair Value |  | 381 |  |  |
Semiconductors |  |  |  |  |
Investment Holdings [Line Items] |  |  |  |  |
Investment Owned At Fair Value |  | $ 20,621 |  | $ 22,498 |
Semiconductors | Warrant |  |  |  |  |
Investment Holdings [Line Items] |  |  |  |  |
Investment owned, percent of net assets | [1] | 0.05% |  |  |
Semiconductors | Equity |  |  |  |  |
Investment Holdings [Line Items] |  |  |  |  |
Investment owned, percent of net assets |  | 0.02% | [1] | 0.06% | [3]
Investment Owned At Cost |  | $ 160 | [2] | $ 160 | [4]
Investment Owned At Fair Value |  | 259 |  | $ 725 |
Semiconductors | Warrant Investment |  |  |  |  |
Investment Holdings [Line Items] |  |  |  |  |
Investment owned, percent of net assets | [3] |  |  | 0.21% |
Investment Owned At Cost |  | 850 | [2] | $ 850 | [4]
Investment Owned At Fair Value |  | $ 715 |  | $ 2,701 |
Semiconductors | Debt Investment [Member] |  |  |  |  |
Investment Holdings [Line Items] |  |  |  |  |
Investment owned, percent of net assets |  | 1.44% | [1] | 1.46% | [3]
Manufacturing Technology | Warrant |  |  |  |  |
Investment Holdings [Line Items] |  |  |  |  |
Investment owned, percent of net assets | [1] | 0.32% |  |  |
Manufacturing Technology | Warrant Investment |  |  |  |  |
Investment Holdings [Line Items] |  |  |  |  |
Investment Owned At Cost | [2] | $ 726 |  |  |
Investment Owned At Fair Value |  | $ 4,338 |  |  |
Manufacturing Technology | Debt Investment [Member] |  |  |  |  |
Investment Holdings [Line Items] |  |  |  |  |
Investment owned, percent of net assets |  | 2.90% | [1] | 1.15% | [3]
Information Services |  |  |  |  |
Investment Holdings [Line Items] |  |  |  |  |
Investment Owned At Fair Value |  | $ 59,735 |  | $ 74,417 |
Information Services | Warrant |  |  |  |  |
Investment Holdings [Line Items] |  |  |  |  |
Investment owned, percent of net assets | [1] | 0.03% |  |  |
Information Services | Equity |  |  |  |  |
Investment Holdings [Line Items] |  |  |  |  |
Investment owned, percent of net assets |  | 0.56% | [1] | 0.72% | [3]
Investment Owned At Cost |  | $ 4,440 | [2] | $ 4,440 | [4]
Investment Owned At Fair Value |  | 7,579 |  | $ 9,414 |
Information Services | Warrant Investment |  |  |  |  |
Investment Holdings [Line Items] |  |  |  |  |
Investment owned, percent of net assets | [3] |  |  | 0.04% |
Investment Owned At Cost |  | 680 | [2] | $ 645 | [4]
Investment Owned At Fair Value |  | $ 416 |  | $ 557 |
Information Services | Debt Investment [Member] |  |  |  |  |
Investment Holdings [Line Items] |  |  |  |  |
Investment owned, percent of net assets |  | 3.80% | [1] | 4.93% | [3]
[1] | Value as a percent of net assets. All amounts are stated in U.S. Dollars unless otherwise noted. The Company uses the Standard Industrial Code for classifying the industry grouping of its portfolio companies
[2] | Gross unrealized appreciation, gross unrealized depreciation, and net unrealized depreciation for federal income tax purposes totaled $68.4 million, $110.0 million and $41.6 million, respectively. The tax cost of investments is $2.9 billion.
[3] | Value as a percent of net assets. All amounts are stated in U.S. Dollars unless otherwise noted. The Company uses the Standard Industrial Code for classifying the industry grouping of its portfolio companies.
[4] | Gross unrealized appreciation, gross unrealized depreciation, and net unrealized depreciation for federal income tax purposes totaled $121.0 million, $75.7 million, and $45.3 million, respectively. The tax cost of investments is $2.4 billion.
[5] | Except for warrants in 26 publicly traded companies and common stock in 36 publicly traded companies, all investments are restricted as of December 31, 2021 and were valued at fair value using Level 3 significant unobservable inputs as determined in good faith by the Company’s Board.

X
- Definition Number of publicly traded companies. + References No definition available. + Details
Name: | htgc_NumberOfPubliclyTradedCompanies
Namespace Prefix: | htgc_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | instant

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_InvestmentHoldingsLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Rate of interest on investment. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 320 -SubTopic 10 -Section 50 -Paragraph 5 -URI https://asc.fasb.org/extlink&oid=126970911&loc=d3e27232-111563 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 320 -SubTopic 10 -Section 50 -Paragraph 2 -URI https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563 + Details
Name: | us-gaap_InvestmentInterestRate
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition Cost of the investment. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 946 -SubTopic 210 -Section 50 -Paragraph 6 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=99383244&loc=d3e12121-115841 + Details
Name: | us-gaap_InvestmentOwnedAtCost
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Value of the investment at close of period. For schedules of investments that are categorized, the value would be aggregated by category. For investment in and advances to affiliates, if operations of any controlled companies are different in character from those of the company, group such affiliates within divisions and by type of activities. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 946 -SubTopic 210 -Section 50 -Paragraph 6 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=99383244&loc=d3e12121-115841 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 946 -SubTopic 320 -Section S99 -Paragraph 5D -Subparagraph (SX 210.12-13D(Column C)) -URI https://asc.fasb.org/extlink&oid=122147990&loc=SL120429264-123010 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 946 -SubTopic 320 -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-12B(Column C)) -URI https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010 + Details
Name: | us-gaap_InvestmentOwnedAtFairValue
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition For investments which are quantified by principal amount, the principle balance held at close of period. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 946 -SubTopic 210 -Section 50 -Paragraph 6 -Subparagraph (c) -URI https://asc.fasb.org/extlink&oid=99383244&loc=d3e12121-115841 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 946 -SubTopic 320 -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-12B(Column B)) -URI https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010 + Details
Name: | us-gaap_InvestmentOwnedBalancePrincipalAmount
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Percent of net assets at close of period. For schedules of investments that are categorized, each category has a percent of net assets for the aggregated value of the Investments in the category. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 946 -SubTopic 320 -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-12B(Column D)) -URI https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 946 -SubTopic 210 -Section 50 -Paragraph 6 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=99383244&loc=d3e12121-115841 + Details
Name: | us-gaap_InvestmentOwnedPercentOfNetAssets
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition The aggregate cost of investments for Federal income tax purposes. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 946 -SubTopic 10 -Section S99 -Paragraph 3 -Subparagraph (SX 210.6-03(h)(2)(iv)) -URI https://asc.fasb.org/extlink&oid=126898976&loc=d3e600178-122990 + Details
Name: | us-gaap_TaxBasisOfInvestmentsCostForIncomeTaxPurposes
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Aggregate gross unrealized appreciation for all Investments in which there is an excess of value over tax cost. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 946 -SubTopic 10 -Section S99 -Paragraph 3 -Subparagraph (SX 210.6-03(h)(2)(i)) -URI https://asc.fasb.org/extlink&oid=126898976&loc=d3e600178-122990 + Details
Name: | us-gaap_TaxBasisOfInvestmentsGrossUnrealizedAppreciation
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition The aggregate gross unrealized depreciation for all Investments in which there is an excess of tax cost over value. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 946 -SubTopic 10 -Section S99 -Paragraph 3 -Subparagraph (SX 210.6-03(h)(2)(ii)) -URI https://asc.fasb.org/extlink&oid=126898976&loc=d3e600178-122990 + Details
Name: | us-gaap_TaxBasisOfInvestmentsGrossUnrealizedDepreciation
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition The net unrealized appreciation or depreciation. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 946 -SubTopic 10 -Section S99 -Paragraph 3 -Subparagraph (SX 210.6-03(h)(2)(iii)) -URI https://asc.fasb.org/extlink&oid=126898976&loc=d3e600178-122990 + Details
Name: | us-gaap_TaxBasisOfInvestmentsUnrealizedAppreciationDepreciationNet
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Details
Name: | us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis=htgc_BlackCrowAIIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_DebtInstrumentAxis=htgc_PromissoryNotesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FinancialInstrumentAxis=htgc_PRIMEInterestRateMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FinancialInstrumentAxis=htgc_OneMonthLIBORMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FinancialInstrumentAxis=htgc_ThreeMonthLIBORMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FinancialInstrumentAxis=htgc_SixMonthLIBORMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FairValueByAssetClassAxis=us-gaap_WarrantMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FairValueByAssetClassAxis=htgc_TotalInvestmentsBeforeCashAndCashEquivalentMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FairValueByAssetClassAxis=htgc_TotalInvestmentInSecuritiesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FairValueByAssetClassAxis=htgc_TotalInvestmentsWithCashAndCashEquivalentMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FairValueByAssetClassAxis=us-gaap_MoneyMarketFundsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FairValueByAssetClassAxis=htgc_InvestmentFundsAndVehiclesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FairValueByAssetClassAxis=us-gaap_CommonStockMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentSecondaryCategorizationAxis=htgc_EquityInvestmentsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentSecondaryCategorizationAxis=htgc_WarrantInvestmentMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentSecondaryCategorizationAxis=htgc_DebtInvestmentMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentSecondaryCategorizationAxis=htgc_InvestmentsInSecuritiesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentSecondaryCategorizationAxis=htgc_InvestmentFundsVehiclesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentSecondaryCategorizationAxis=htgc_InvestmentMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=htgc_PhathomPharmaceuticalsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentSecondaryCategorizationAxis=htgc_RoyaltyContractMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=htgc_InternetConsumerAndBusinessServicesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=htgc_SurgicalDevicesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=htgc_MediaContentInfoMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=htgc_ConsumerAndBusinessProductsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=htgc_DiversifiedFinancialServicesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=htgc_ElectronicsComputerHardwareMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=htgc_HealthcareServicesOtherMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=htgc_DrugDeliveryMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=htgc_CommunicationsAndNetworkingMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=htgc_DrugDiscoveryAndDevelopmentMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=htgc_MedicalDevicesAndEquipmentMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=htgc_SustainableAndRenewableTechnologyMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=htgc_SoftwareMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=htgc_SemiconductorsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=htgc_ManufacturingTechnologyMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=htgc_InformationServicesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |